Dr. Cohen is the chief of the division of gastroenterology and hepatology at the Weill department of medicine. He is a member of the American Society for Clinical Investigation and is a physician scientist who focuses on the molecular regulation of glucose and hepatic lipid metabolism.
Through his research at the Cohen Laboratory, Dr. Cohen discovered small molecular inhibitors of phosphatidylcohline transfer protein, demonstrating how they could increase hepatic insulin sensitivity.
In 2016, he became the editor of Hepatology.
More articles on gastroenterology:
Cantel Medical taps Bill Haydon as new SVP, general manager of medical division
Texas gastroenterologist killed in car crash
GI leader to know: Dr. Philip Styne of Florida Hospital
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.